J VASC INTERV RADIOL 润色咨询

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

出版年份:1990 年文章数:3607 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:13.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2020-06-22 erudite

    请问一下各位大神 ICMJE disclosure form 在哪里下载?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2022-03-19 ms1814256470477447

    JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2022-07-09 ms4000000331446047

    偏重的研究方向:血管介入;介入放射学
    经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2019-01-19 我笨阳光

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2021-12-31 ms9000000177483177

    请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    模式图一般放在讨论中展示还是放在结果部分?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    讨论中第一段一定要撰写文章的总括么?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2019-01-19 我笨阳光

    1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2020-12-28 ms1814256470477447

    JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=799368, encodeId=0602e9936872, content=请问一下各位大神 ICMJE disclosure form 在哪里下载?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f4581048, createdName=erudite, createdTime=Mon Jun 22 13:11:28 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204218, encodeId=bad3120421871, content=JVIR是介入放射学领域的顶级杂志,虽然IF3.464,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快,审稿人很专业。我们2019年和2021年发了两篇骨转移微创治疗方面的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Sat Mar 19 23:07:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231423, encodeId=e4d012314236b, content=偏重的研究方向:血管介入;介入放射学<br>经验分享:投稿22天状态由under review变为required reviews completed后又持续了快10天,想问一下这个意味着是不是离拒稿不远了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=ms4000000331446047, createdTime=Sat Jul 09 01:40:06 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565766, encodeId=8b4b565e666b, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:09:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179087, encodeId=35d211e908769, content=请问有老师知道这个杂志审稿周期吗?或者有这个期刊投稿经验的方便分享投稿经验吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db675462277, createdName=ms9000000177483177, createdTime=Fri Dec 31 08:47:42 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094386, encodeId=cf99109438628, content=模式图一般放在讨论中展示还是放在结果部分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094385, encodeId=81ca109438571, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565767, encodeId=a527565e6793, content=1208年11月8号投稿,12月3号状态变为under editor evaluation, 12月17号状态变为decision in process, 到现在还是这个状态,请问有这样的吗? 是主编太忙了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=701b2039839, createdName=我笨阳光, createdTime=Sat Jan 19 11:24:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911644, encodeId=3905911644d2, content=JVIR是介入医学领域的顶级杂志,虽然IF3.0,但在介入放射学领域威望很高。编辑很负责,审稿速度比较快。我们2019年发了一篇微波联合骨水泥治疗脊柱外转移的论文,不要版面费,很好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b4d1cb5c84994cdd8c320df7bf1258a9/8a85ded8d01d4fe69b2d493d5eabfa83.jpg, createdBy=de1e1882920, createdName=ms1814256470477447, createdTime=Mon Dec 28 16:57:47 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913959, encodeId=622c9139598e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95f74843627, createdName=xushengir, createdTime=Tue Jan 05 20:39:02 CST 2021, time=2021-01-05, status=1, ipAttribution=)]
    2021-01-05 xushengir

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:10月投稿,11月初修回,先后修改三次,12月底接收。速度还可以,至于难度,还得看文章内容。新技术临床细节比较受欢迎。

    0

共30条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分